Cited by 18Regulation of Appetite and ObesityNeuropeptides and Animal PhysiologyHypothalamic control of reproductive hormones

Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice

Open access
Adank, Danielle N., Lunzer, Mary M., Lensing, Cody J., Wilber, Stacey L., Gancarz, Amy M., Haskell-Luevano, Carrie·2018·ACS Chemical Neuroscience

Abstract

Central administration of melanocortin ligands has been used as a critical technique to study energy homeostasis. While intracerebroventricular (ICV) injection is the most commonly used method during these investigations, intrathecal (IT) injection can be equally efficacious for the central delivery of ligands. Importantly, intrathecal administration can optimize exploration of melanocortin receptors in the spinal cord. Herein, we investigate comparative IT and ICV administration of two melanocortin ligands, the synthetic MTII (Ac-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-NH 2 ) MC4R agonist and agouti-related peptide [AGRP(87-132)] MC4R inverse agonist/antagonist, on the same batch of age-matched mice in TSE metabolic cages undergoing a nocturnal satiated paradigm. To our knowledge, this is the first study to test how central administration of these ligands directly to the spinal cord affects energy homeostasis. Results showed, as expected, that MTII IT administration caused a decrease in food and water intake and an overall negative energy balance without affecting activity. As anticipated, IT administration of AGRP caused weight gain, increase of food/water intake, and increase respiratory exchange ratio (RER). Unexpectantly, the prolonged activity of AGRP was notably shorter (2 days) compared to mice given ICV injections of the same concentrations in previous studies (7 days or more).1−4 It appears that IT administration results in a more sensitive response that may be a good approach for testing synthetic compound potency values ranging in nanomolar to high micromolar in vitro EC 50 values. Indeed, our investigation reveals that the spine influences a different melanocortin response compared to the brain for the AGRP ligand. This study indicates that IT administration can be a useful technique for future metabolic studies using melanocortin ligands and highlights the importance of exploring the role of melanocortin receptors in the spinal cord.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acschemneuro.7b00330

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Compared to intracerebroventricular and intracisternal magna administration, intrathecal injection can generate a broader and more homogeneous distribution of therapeutics throughout the entire brain via CSF circulation.

    “Compared to other CNS injection routes, such as intracerebroventricular (ICV) and intracisternal magna (ICM) administration, IT injection can generate a broader and more homogeneous distribution of therapeutics throughout the entire bran via CSF circulation.[22]”

    From Lipid Nanoparticles Enhance mRNA Delivery to the Central Nervous System Upon Intrathecal Injection (2025) · cites this paper as [22]

    The Results and Discussion section says that compounds injected intrathecally can reach the brain, citing small amounts detected there after 20 minutes (page unavailable). It does not establish broader or more homogeneous distribution throughout the entire brain than ICV injection, does not compare IT with intracisternal magna injection, and does not attribute the movement to CSF circulation. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 34

  1. [1]Irani BG Xiang Z Yarandi HN Holder JR Moore MC Bauzo RM Proneth B Shaw AM Millard WJ Chambers JB Benoit SC Clegg DJ Haskell-Luevano C 2011 Implication of the melanocortin-3 receptor in the regulation of food intake Eur J Pharmacol 660 80 87 21199647 PMC3095750
  2. [2]Goodin SZ Kiechler AR Smith M Wendt D Strader AD 2008 Effect of gonadectomy on AgRP-induced weight gain in rats Am J Physiol Regul Integr Comp Physiol 295 R1747 1753 18922963
  3. [3]Hagan MM Rushing PA Pritchard LM Schwartz MW Strack AM Van Der Ploeg LH Woods SC Seeley RJ 2000 Long-term orexigenic effects of AgRP-(83-132) involve mechanisms other than melanocortin receptor blockade Am J Physiol Regul Integr Comp Physiol 279 R47 52 10896863
  4. [4]Tang-Christensen M Vrang N Ortmann S Bidlingmaier M Horvath TL Tschop M 2004 Central administration of ghrelin and agouti-related protein (83-132) increases food intake and decreases spontaneous locomotor activity in rats Endocrinology 145 4645 4652 15231700
  5. [5]Kuo A Smith MT 2014 Theoretical and practical applications of the intracerebroventricular route for CSF sampling and drug administration in CNS drug discovery research: a mini review J Neurosci Methods 233 166 171 24937765
  6. [6]Fan W Boston BA Kesterson RA Hruby VJ Cone RD 1997 Role of melanocortinergic neurons in feeding and the agouti obesity syndrome Nature 385 165 168 8990120
  7. [7]Hruby VJ Lu D Sharma SD Castrucci AL Kesterson RA al-Obeidi FA Hadley ME Cone RD 1995 Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors J Med Chem 38 3454 3461 7658432
  8. [8]Rowland NE Schaub JW Robertson KL Andreasen A Haskell-Luevano C 2010 Effect of MTII on food intake and brain c-Fos in melanocortin-3, melanocortin-4, and double MC3 and MC4 receptor knockout mice Peptides 31 2314 2317 20800636 PMC2967649
  9. [9]Pierroz DD Ziotopoulou M Ungsunan L Moschos S Flier JS Mantzoros CS 2002 Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity Diabetes 51 1337 1345 11978628
  10. [10]Murphy B Nunes CN Ronan JJ Hanaway M Fairhurst AM Mellin TN 2000 Centrally administered MTII affects feeding, drinking, temperature, and activity in the Sprague-Dawley rat J Appl Physiol 89 273 282 10904062
  11. [11]Lute B Jou W Lateef DM Goldgof M Xiao C Pinol RA Kravitz AV Miller NR Huang YG Girardet C Butler AA Gavrilova O Reitman ML 2014 Biphasic effect of melanocortin agonists on metabolic rate and body temperature Cell Metab 20 333 345 24981835 PMC4126889
  12. [12]Chen AS Metzger JM Trumbauer ME Guan XM Yu H Frazier EG Marsh DJ Forrest MJ Gopal-Truter S Fisher J Camacho RE Strack AM Mellin TN MacIntyre DE Chen HY Van der Ploeg LH 2000 Role of the melanocortin-4 receptor in metabolic rate and food intake in mice Transgenic Res 9 145 154 10951699
  13. [13]Kublaoui BM Holder JL Jr Gemelli T Zinn AR 2006 Sim1 haploinsufficiency impairs melanocortin-mediated anorexia and activation of paraventricular nucleus neurons Mol Endocrinol 20 2483 2492 16728530
  14. [14]Bertorelli R Fredduzzi S Tarozzo G Campanella M Grundy R Beltramo M Reggiani A 2005 Endogenous and exogenous melanocortin antagonists induce anti-allodynic effects in a model of rat neuropathic pain Behav Brain Res 157 55 62 15617771
  15. [15]Bellasio S Nicolussi E Bertorelli R Reggiani A 2003 Melanocortin receptor agonists and antagonists modulate nociceptive sensitivity in the mouse formalin test Euro J Pharmacol 482 127 132 14660013
  16. [16]Hylden JL Wilcox GL Intrathecal morphine in mice: a new technique 1980 Euro J Pharmacol 67 313 316 6893963
  17. [17]Lensing CJ Adank DN Doering SR Wilber SL Andreasen A Schaub JW Xiang Z Haskell-Luevano C 2016 Ac-Trp-DPhe(p-I)-Arg-Trp-NH2, a 250-Fold Selective Melanocortin-4 Receptor (MC4R) Antagonist over the Melanocortin-3 Receptor (MC3R), Affects Energy Homeostasis in Male and Female Mice Differently ACS Chem Neuro 7 1283 1291 PMC5687811 27385405
  18. [18]Lensing CJ Freeman KT Schnell SM Adank DN Speth RC Haskell-Luevano C 2016 An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers J Med Chem 59 3112 3128 26959173 PMC5679017
  19. [19]Lensing CJ Adank DN Wilber SL Freeman KT Schnell SM Speth RC Zarth AT Haskell-Luevano C 2017 A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage ACS Chem Neuro 8 1262 1278 PMC5679024 28128928
  20. [20]Marsh DJ Hollopeter G Huszar D Laufer R Yagaloff KA Fisher SL Burn P Palmiter RD 1999 Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides Nat Genet 21 119 122 9916804
  21. [21]Franklin KBJ Paxinos G 1997 The mouse brain in stereotaxic coordinates Academic Press San Diego
  22. [22]Lunzer MM Portoghese PS 2007 Selectivity of delta- and kappa-opioid ligands depends on the route of central administration in mice J Pharmacol Exp Ther 322 166 171 17400888
  23. [23]Le Naour M Lunzer MM Powers MD Portoghese PS 2012 Opioid activity of spinally selective analogues of N-naphthoyl-beta-naltrexamine in HEK-293 cells and mice J Med Chem 55 670 677 22136373 PMC3438918
  24. [24]Speakman JR 2013 Measuring energy metabolism in the mouse - theoretical, practical, and analytical considerations Front Physiol 4 34 23504620 PMC3596737
  25. [25]Meyer CW Reitmeir P Tschop MH 2015 Exploration of Energy Metabolism in the Mouse Using Indirect Calorimetry: Measurement of Daily Energy Expenditure (DEE) and Basal Metabolic Rate (BMR) Curr Protoc Mouse Biol 5 205 222 26331756
  26. [26]Ellacott KL Morton GJ Woods SC Tso P Schwartz MW 2010 Assessment of feeding behavior in laboratory mice Cell Metab 12 10 17 20620991 PMC2916675
  27. [27]Teegarden SL Bale TL 2008 Effects of stress on dietary preference and intake are dependent on access and stress sensitivity Physiol Behav 93 713 723 18155095 PMC2483328
  28. [28]Bonsall DR Kim H Tocci C Ndiaye A Petronzio A McKay-Corkum G Molyneux PC Scammell TE Harrington ME 2015 Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1beta: Investigating a Method for the Study of Fatigue in Laboratory Animals PloS One 10 e0140678 26469939 PMC4607158
  29. [29]Wilson BD Bagnol D Kaelin CB Ollmann MM Gantz I Watson SJ Barsh GS 1999 Physiological and anatomical circuitry between Agouti-related protein and leptin signaling Endocrinology 140 2387 2397 10218993
  30. [30]Liu H Kishi T Roseberry AG Cai X Lee CE Montez JM Friedman JM Elmquist JK 2013 Transgenic mice expressing green fluorescent protein under the control of the melanocortin-4 receptor promoter J Neurosci 23 7143 7154 PMC6740648 12904474
  31. [31]Mountjoy KG Wild JM 1998 Melanocortin-4 receptor mRNA expression in the developing autonomic and central nervous systems Dev Brain Res 107 309 314 9593962
  32. [32]Starowicz K Bilecki W Sieja A Przewlocka B Przewlocki R 2004 Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats Neurosci Lett 358 79 82 15026153
  33. [33]van der Kraan M Tatro JB Entwistle ML Brakkee JH Burbach JP Adan RA Gispen WH 1999 Expression of melanocortin receptors and pro-opiomelanocortin in the rat spinal cord in relation to neurotrophic effects of melanocortins Mol Brain Res 63 276 286 9878783
  34. [34]Sohn JW Harris LE Berglund ED Liu T Vong L Lowell BB Balthasar N Williams KW Elmquist JK 2013 Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons Cell 152 612 619 23374353 PMC3711728

Cited by

Sorted by citations

Authors
Adank, D. N., Lunzer, M. M., Lensing, C. J., Wilber, S. L., Gancarz, A. M., & Haskell-Luevano, C.
Affiliations
  • University of Minnesota (US)
  • California State University, Bakersfield (US)
  • Department of Medicinal Chemistry, University of Minnesota, Minneapolis, Minnesota 55455, United States
Venue
ACS Chemical Neuroscience
Published
2017-10-19
Volume
9
Issue
2
Pages
320-327
ISSN
1948-7193 (ISSN-L)
OpenAlex
W2762426178
Cited by
18
References
0
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 2 · 2018: 3
FWCI
1.17
Type
journal article
Language
en
Open access
Locations
  • ACS Chemical Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK091906, R01DK108893)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
intrathecal administration, intracerebroventricular administration, melanin-concentrating hormone, agouti-related protein, melanocortin-4 receptor, energy homeostasis, spinal cord, dietary intake, energy balance, respiratory exchange ratio, ligand potency
MeSH terms
alpha-MSH, Animals, Body Weight, Catheters, Indwelling, Eating, Homeostasis, Injections, Intraventricular, Injections, Spinal, Male, Mice, Inbred C57BL, Peptide Fragments, Time Factors, Cross-Over Studies, Receptor, Melanocortin, Type 4, Agouti-Related Protein, Mice, 129 Strain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review